tiprankstipranks
Bioscience Neutraceuticals Inc (DEVV)
OTHER OTC:DEVV
US Market

Bioscience Neutraceuticals (DEVV) Financial Statements

0 Followers

Bioscience Neutraceuticals Financial Overview

Bioscience Neutraceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Bioscience Neutraceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 19Sep 19Jun 19Mar 19Dec 18
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit-$ 0.00---
EBIT$ -4.76K$ -3.98K$ -10.09K$ -440.92K$ -13.34K
EBITDA$ -4.76K$ -3.98K$ -10.09K$ -440.92K$ -13.34K
Net Income Common Stockholders$ -154.37K$ -9.27K$ -15.31K$ -447.10K$ -23.81K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments-----
Total Assets$ 0.00$ 0.00$ 0.00$ 0.00$ 6.00K
Total Debt$ 46.34K$ 50.38K$ 179.69K$ 0.00$ 0.00
Net Debt$ 46.34K$ 50.38K$ 179.69K$ 0.00$ 0.00
Total Liabilities$ 244.14K$ 227.09K$ 217.82K$ 202.50K$ 191.32K
Stockholders Equity$ -244.14K$ -227.09K$ -217.82K$ -202.50K$ -185.32K
Cash Flow-
Free Cash Flow$ -4.89K$ -3.64K$ -21.36K$ -7.25K$ -15.38K
Operating Cash Flow$ -4.89K$ -3.64K$ -21.36K$ -7.25K$ -15.38K
Investing Cash Flow----$ -1.09K
Financing Cash Flow$ 4.89K$ 3.64K$ 21.36K$ 7.25K$ 15.38K
Currency in USD

Bioscience Neutraceuticals Earnings and Revenue History

Bioscience Neutraceuticals Debt to Assets

Bioscience Neutraceuticals Cash Flow

Bioscience Neutraceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis